Clinical Trials
Kodiak begins three phase 3 studies of anti-VEGF antibody biopolymer conjugate, KSI-301 to treat DME and macular edema due to retinal vein occlusion
Kodiak Sciences Inc., a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced that the first...
News
Blue Dart strengthens temperature controlled logistics solution to fight against COVID-19
Blue Dart, India’s leading express logistics service provider and part of the Deutsche Post DHL Group (DPDHL) with its commitment to help improve the...
Press Releases
Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR -COV19 vaccine candidate
Recipharm, a leading contract development and manufacturing organisation (CDMO) has entered into an agreement with Arcturus Therapeutics, a leading U.S. based clinical-stage messenger RNA...
Drug Research
Eisai enters joint research pact with four research organizations in Japan for development of therapeutics for novel COVID-19
Eisai Co Ltd announced that it has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global...
News
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis
Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11,...
News
Gilead takes over distribution of Covid-19 antiviral drug from federal government
The maker of the first antiviral drug to get authorization from regulators for Covid-19 anticipates meeting real-time demand for it around the world this...
Clinical Trials
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read